AA SLE patients had significantly higher percentages of patients with anti-RNP autoantibodies (62%) compared with EA (30%) and NAA (51%), and significantly higher percentages of patients with anti-Sm (24%) compared with EA (12%) (Supplemental Table 11). The gene discussed is RNPC3; the disease is systemic lupus erythematosus.